Normalized blood transcript levels of HN and MOTS-c showed gradual relationships according to disease states, with the lowest levels in AD patients, slightly higher levels in MCI patients, and the highest levels in controls with subjective cognitive decline (SCD). This evidence concerns the gene MT-RNR1 and Alzheimer disease.